I don't see how going downhill is positive.
If you campare the the 10 settlements up through Sept 30 with the texas group, you will conclude that the average revenue per settlement was lower.
If you compare the current share price with the price from a couple of years ago, it is lower.
No new products in five years.
Nunchi is way behind schedule according to prior edig comments.
Reexam could be positive or negative, waiting for another 6 months, perhaps a year.
Anyone can take a few comments from the report as express them as positive, showing a profit is almost a given if you have patent revenue at 50+% margin. Take a look at the product sales, actually a gross profit loss, last year showed a profit.
